Close the Cancer–Immunity Cycle by Integrating Lipid Nanoparticle–mRNA Formulations and Dendritic Cell Therapy

Researchers combined lipid nanoparticle–mRNA formulations and dendritic cell therapy to boost the cancer–immunity cycle via progressive steps to overcome the immunosuppressive tumor microenvironment.